Prostate cancer experts emphasize early diagnosis and personalized screening

Medical experts and health organizations emphasize the critical importance of early diagnosis for prostate cancer, noting that the disease can progress without presenting any initial symptoms. According to the World Health Organization, approximately 1.5 million men are diagnosed globally each year.

Urology specialist Prof. Dr. İlker Tinay highlights that genetic factors, such as mutations in the BRCA1 and BRCA2 genes—which are commonly associated with breast cancer in women—also pose a risk for prostate cancer in men. Individuals with a family history of breast or prostate cancer are advised to begin regular check-ups starting in their 40s.

Health guidelines from the American Cancer Society and the American Urological Association suggest that screening should not be a one-size-fits-all approach based solely on age. Instead, decisions should be made in consultation with a doctor based on individual risk factors. For instance, men with high-risk profiles may need earlier screening, while those at average risk may begin discussions around age 50. Common symptoms of advanced disease include blood in the urine or semen, difficulty urinating, and pain in the pelvic or lower back regions, but the absence of these symptoms does not rule out the presence of cancer.